Akari TherapeuticsAKTX
13F holders, Q4 2025 (December 31)21holders +5
7new positions
4sold out
$0.29avg. 13F price*
At the end of Q4 2025, 21 institutions reported holding Akari Therapeutics PLC (AKTX) in their 13F filings, up 5 from Q3 2025. 7 opened new positions and 4 sold out. The largest holders were Armistice Capital, LLC ($787K), Cresset Asset Management, LLC ($238K) and Warberg Asset Management LLC ($89K).
- Company
- Akari Therapeutics PLC
- CUSIP
- 00972G207
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $933K |
| Exits | 4 | $71K |
All 13F filers, Q3 2025 → Q4 2025: 3,268,707 shares bought and 75,741 shares sold, net +3,192,966 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Armistice Capital, LLC | 0.02% | New | 2,723,966 | $787K |
| Cresset Asset Management, LLC | 0.00% | No change | 822,468 | $238K |
| Warberg Asset Management LLC | 0.28% | New | 308,340 | $89K |
| Palo Alto Investors LP | 0.01% | No change | 146,024 | $42K |
| HighTower Advisors, LLC | 0.00% | No change | 79,236 | $23K |
| Jane Street Group, LLC | 0.00% | New | 71,644 | $21K |
| SmartHarvest Portfolios, LLC | 0.01% | — | 69,248 | $20K |
| CWA Asset Management Group, LLC | 0.00% | New | 55,000 | $16K |
| XTX Topco Ltd | 0.00% | New | 49,019 | $14K |
| UBS Group AG | 0.00% | Add +54658.3% | 32,855 | $9K |
| Cerity Partners LLC | 0.00% | No change | 23,643 | $7K |
| StoneX Group Inc. | 0.00% | New | 21,295 | $6K |
| Skyview Financial Group LLC | 0.01% | — | 20,575 | $6K |
| Independent Advisor Alliance | 0.00% | Add +56.8% | 17,075 | $5K |
| NewEdge Advisors, LLC | 0.00% | No change | 6,800 | $2K |
| Accent Capital Management, LLC | 0.00% | Reduce -50.0% | 5,000 | $1K |
| Bank of America Corp. | 0.00% | Add +173.3% | 410 | $118 |
| SBI Securities Co., Ltd. | 0.00% | New | 200 | $58 |
| Truvestments Capital LLC | 0.00% | No change | 50 | $14 |
| Morgan Stanley | 0.00% | No change | 3 | $1 |
| Cornerstone Planning Group LLC | 0.00% | Reduce -28.6% | 5 | $1 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC the manager owns.